Guided Therapeutics, Inc. (OTC:GTHP) climbed down from the 52-week high in the last several sessions. The company has announced more positive news though, and one last PR has been saved for today’s session. 
Early in the morning today, GTHP said that it has chosen Eurosurgical Ltd as its exclusive distributor of LuVivaTM Advanced Cervical Scan in the United Kingdom. That new partner is said in the PR to have over 20 years of experience in the healthcare industry and in bringing new products on the market. If that will impress traders will be seen today.
Yesterday’s session closed at $1.36, which is a 2.26% increase from the previous close. The trading volume was again huge, however. With 386,500 traded shares it is at least a few times higher than the daily average for the past three months, suggesting that the share price could increase more today as GTHP strategy to announce good news on time has worked so far.
A previous announcement from yesterday says that LuVivaTM Advanced Cervical Scan has been also approved for sale in Canada by Health Canada. For both of these latest announcement corresponding 8-K filings are still missing, making them thus not confirmed yet.
